Results 131 to 140 of about 8,194 (217)

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis. [PDF]

Eur J Clin Invest, 2021
Aimo A, Rapezzi C, Perfetto F, Cappelli F, Palladini G, Obici L, Merlini G, Di Bella G, Serenelli M, Zampieri M, Milani P, Licordari R, Teresi L, Ribarich N, Castiglione V, Quattrone F, De Rosis S, Vergaro G, Panichella G, Emdin M, Passino C.   +20 more
europepmc   +1 more source

Natural history, Staging and Prognosis in Systemic Amyloidosis [PDF]

Background: Systemic amyloidosis is a rare disorder of protein misfolding and aggregation ranging from indolent localised disease to rapidly progressive multi-organ failure. Systemic light-chain (AL) and transthyretin (ATTR) amyloidosis are the commonest
Law, Steven John
core  

Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study. [PDF]

Circulation
Razvi Y, Rauf MU, Porcari A, Mansell J, Sheikh A, Ioannou A, Whelan CJ, Venneri L, Martinez-Naharro A, Hutt DF, Rowczenio D, Gilbertson JA, Wechalekar AD, Lachmann HJ, Hawkins PN, Fontana M, Gillmore JD.   +16 more
europepmc   +1 more source

ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review. [PDF]

JACC CardioOncol, 2021
Griffin JM, Rosenthal JL, Grodin JL, Maurer MS, Grogan M, Cheng RK.   +5 more
europepmc   +1 more source

The FLC Ratio Reframed: Averting Unnecessary Heart Biopsies in Wild-Type ATTR Amyloidosis. [PDF]

JACC CardioOncol
Muchtar E, Maurer MS.
europepmc   +1 more source

Unraveling a rare cause of spinal stenosis: Coexistent AL and ATTR amyloidosis involving the ligamentum flavum. [PDF]

Surg Neurol Int, 2022
Godara A, Wang AY, Arkun K, Fogaren T, Qamar AS, McPhail ED, Kryzanski J, Riesenburger R, Comenzo R.   +8 more
europepmc   +1 more source

New therapeutic perspectives – amyloid removal [PDF]

, 2015
Mark Pepys
core   +1 more source

Initial Capture Failure With Delayed Resolution in Atrial Leadless Pacemaker Implantation: A Case of ATTR Amyloidosis With Sinus Node Dysfunction. [PDF]

J Arrhythm
Takada Y, Kamoshida J, Terasawa M, Satomi K, Yazaki Y.   +4 more
europepmc   +1 more source

A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey. [PDF]

Neurol Ther, 2021
González-Moreno J, Losada-López I, Cisneros-Barroso E, Garcia-Pavia P, González-Costello J, Muñoz-Beamud F, Campistol JM, Fernandez-Torron R, Chapman D, Amass L.   +9 more
europepmc   +1 more source

Transthyretin Kinetic Stabilizers for ATTR Amyloidosis: A Narrative Review of Mechanisms and Therapeutic Benefits. [PDF]

Cardiol Ther
Powers ET, Amass L, Baylor L, Fernández-Arias I, Riley S, Kelly JW.   +5 more
europepmc   +1 more source